SEC-induced Activation of ANXA7 GTPase Suppresses Prostate Cancer Metastasis

Overview

Journal Cancer Lett

Specialty Oncology

Date 2017 Dec 17

PMID 29247827

Citations 17

Authors

Shuyan Liu

Xiao Li

ZhaoMin Lin

Le Su

Shan Yan

BaoXiang Zhao

Junying Miao

Affiliations

Soon will be listed here.

Abstract

Annexin A7 (ANXA7) is a suppressor of tumorigenesis and metastasis in prostate cancer. Activated ANXA7 GTPase promotes prostate cancer cell apoptosis. However, the role and underlying mechanism of ANXA7 GTPase in prostate cancer metastasis have not been established. RKIP is a metastatic suppressor and downregulated in prostate cancer metastases. The binding of RKIP and its target proteins could inhibit the activation of its interactive partners. However, the effect of RKIP on ANXA7 GTPase activation is not clear. Here, we report that activation of ANXA7 GTPase by a small molecule SEC ((S)-ethyl 1-(3-(4-chlorophenoxy)-2-hydroxypropyl)-3- (4-methoxyphenyl)-1H-pyrazole-5-carboxylate) effectively inhibited prostate cancer metastasis. Mechanistically, activated ANXA7 promoted AMPK phosphorylation, leading to decreased mTORC1 activity, suppressed STAT3 nuclear translocation, and downregulation of pro-metastatic genes, including CCL2, APLN, and IL6ST. Conversely, RKIP interacted with ANXA7 and impaired activation of ANXA7 GTPase by SEC and its downstream signaling pathway. Notably, SEC treatment suppressed metastasis of prostate cancer cells in in vivo orthotopic analysis. Together, our findings provide a novel insight into how metastasis of prostate cancer with low RKIP expression is suppressed by SEC-induced activation of ANXA7 GTPase via the AMPK/mTORC1/STAT3 signaling pathway.

Citing Articles

TransGEM: a molecule generation model based on Transformer with gene expression data.

Liu Y, Yu H, Duan X, Zhang X, Cheng T, Jiang F Bioinformatics. 2024; 40(5).

PMID: 38632084 PMC: 11078772. DOI: 10.1093/bioinformatics/btae189.

Annexin A7 and Its Related Protein Suppressor of Death Domains Regulates Migration and Proliferation of Hca-P Cells.

Wang S, Bai Q, Yu X, Gao F, Sun Y, Wang X Cell J. 2023; 25(11):801-808.

PMID: 38071412 PMC: 10711291. DOI: 10.22074/cellj.2023.559724.1108.

AnnexinA6: a potential therapeutic target gene for extracellular matrix mineralization.

Yang J, Pei T, Su G, Duan P, Liu X Front Cell Dev Biol. 2023; 11:1201200.

PMID: 37727505 PMC: 10506415. DOI: 10.3389/fcell.2023.1201200.

Targeting ANXA7/LAMP5-mTOR axis attenuates spinal cord injury by inhibiting neuronal apoptosis via enhancing autophagy in mice.

Li N, Chen L, Zhao X, Gu C, Chang Y, Feng S Cell Death Discov. 2023; 9(1):309.

PMID: 37620352 PMC: 10449888. DOI: 10.1038/s41420-023-01612-w.

New insights into lipid metabolism and prostate cancer (Review).

Zhang Z, Wang W, Kong P, Feng K, Liu C, Sun T Int J Oncol. 2023; 62(6).

PMID: 37203395 PMC: 10198711. DOI: 10.3892/ijo.2023.5522.

References

Beach S, Tang H, Park S, Dhillon A, Keller E, Kolch W . Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene. 2007; 27(15):2243-8. PMC: 2933472. DOI: 10.1038/sj.onc.1210860. View

Trakul N, Menard R, Schade G, Qian Z, Rosner M . Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem. 2005; 280(26):24931-40. DOI: 10.1074/jbc.M413929200. View

Srivastava M, Bubendorf L, Srikantan V, Fossom L, Nolan L, Glasman M . ANX7, a candidate tumor suppressor gene for prostate cancer. Proc Natl Acad Sci U S A. 2001; 98(8):4575-80. PMC: 31876. DOI: 10.1073/pnas.071055798. View

Rajkumar K, Nichita A, Anoor P, Raju S, Satyanarayana Singh S, Burgula S . Understanding perspectives of signalling mechanisms regulating PEBP1 function. Cell Biochem Funct. 2016; 34(6):394-403. DOI: 10.1002/cbf.3198. View

Huang C, Wu D, Khan F, Jiao X, Guan K, Huo L . The GTPase SPAG-1 orchestrates meiotic program by dictating meiotic resumption and cytoskeleton architecture in mouse oocytes. Mol Biol Cell. 2016; 27(11):1776-85. PMC: 4884068. DOI: 10.1091/mbc.E16-02-0132. View

Hauselmann I, Roblek M, Protsyuk D, Huck V, Knopfova L, Grassle S . Monocyte Induction of E-Selectin-Mediated Endothelial Activation Releases VE-Cadherin Junctions to Promote Tumor Cell Extravasation in the Metastasis Cascade. Cancer Res. 2016; 76(18):5302-12. PMC: 6322653. DOI: 10.1158/0008-5472.CAN-16-0784. View

Ai D, Jiang H, Westerterp M, Murphy A, Wang M, Ganda A . Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis. Circ Res. 2014; 114(10):1576-84. PMC: 4058053. DOI: 10.1161/CIRCRESAHA.114.302313. View

Akinyeke T, Matsumura S, Wang X, Wu Y, Schalfer E, Saxena A . Metformin targets c-MYC oncogene to prevent prostate cancer. Carcinogenesis. 2013; 34(12):2823-32. PMC: 3845895. DOI: 10.1093/carcin/bgt307. View

Roth I, Campbell H, Rubio C, Vennin C, Wilson M, Wiles A . The Δ133p53 isoform and its mouse analogue Δ122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2. Oncogene. 2016; 35(38):4981-9. DOI: 10.1038/onc.2016.45. View

10.

Huang C, Li N, Li Z, Chang A, Chen Y, Zhao T . Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression. Nat Commun. 2017; 8:14035. PMC: 5253665. DOI: 10.1038/ncomms14035. View

11.

Yokogami K, Wakisaka S, Avruch J, Reeves S . Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol. 2000; 10(1):47-50. DOI: 10.1016/s0960-9822(99)00268-7. View

12.

Yin Y, Shen W . PTEN: a new guardian of the genome. Oncogene. 2008; 27(41):5443-53. DOI: 10.1038/onc.2008.241. View

13.

Carling D, Mayer F, Sanders M, Gamblin S . AMP-activated protein kinase: nature's energy sensor. Nat Chem Biol. 2011; 7(8):512-8. DOI: 10.1038/nchembio.610. View

14.

Rehman G, Shehzad A, Khan A, Hamayun M . Role of AMP-activated protein kinase in cancer therapy. Arch Pharm (Weinheim). 2014; 347(7):457-68. DOI: 10.1002/ardp.201300402. View

15.

Chen W, Pan Y, Wang S, Liu Y, Chen G, Zhou L . Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells. BMC Cancer. 2017; 17(1):34. PMC: 5219700. DOI: 10.1186/s12885-016-3038-y. View

16.

Abroun S, Saki N, Ahmadvand M, Asghari F, Salari F, Rahim F . STATs: An Old Story, Yet Mesmerizing. Cell J. 2015; 17(3):395-411. PMC: 4601860. DOI: 10.22074/cellj.2015.1. View

17.

Bucquoy S, Jolles P, Schoentgen F . Relationships between molecular interactions (nucleotides, lipids and proteins) and structural features of the bovine brain 21-kDa protein. Eur J Biochem. 1994; 225(3):1203-10. DOI: 10.1111/j.1432-1033.1994.1203b.x. View

18.

Fu Z, Smith P, Zhang L, Rubin M, Dunn R, Yao Z . Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003; 95(12):878-89. DOI: 10.1093/jnci/95.12.878. View

19.

Farooqi A, Li Y, Sarkar F . The biological complexity of RKIP signaling in human cancers. Exp Mol Med. 2015; 47:e185. PMC: 4650930. DOI: 10.1038/emm.2015.70. View

20.

Park J, Eisenberger M . Advances in the Treatment of Metastatic Prostate Cancer. Mayo Clin Proc. 2015; 90(12):1719-33. DOI: 10.1016/j.mayocp.2015.10.010. View